A multicenter, randomized trial of prophylactic rhSOD has been performed to determine whether intratracheal treatment significantly reduced the incidence of BPD and improved pulmonary outcome at 1 ...

To examine the long-term effects of treatment with recombinant human CuZn superoxide dismutase (rhSOD) in infants enrolled previously in two placebo-controlled trials. Records for 46 (88% ...

A study by researchers at Brigham and Women's Hospital (BWH) suggests that the antioxidant, rhSOD (recombinant human Cu/Zn superoxide dismutase), reduces the risk of developing ROP in extremely ...